HHM Wealth Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.6K Hold
450
﹤0.01% 403
2026
Q1
$39K Hold
450
﹤0.01% 402
2025
Q4
$38.2K Hold
450
﹤0.01% 398
2025
Q3
$32.7K Hold
450
﹤0.01% 438
2025
Q2
$29.5K Hold
450
﹤0.01% 450
2025
Q1
$31.8K Hold
450
﹤0.01% 437
2024
Q4
$29.6K Hold
450
﹤0.01% 438
2024
Q3
$31.8K Hold
450
﹤0.01% 404
2024
Q2
$29.8K Hold
450
﹤0.01% 401
2024
Q1
$30.6K Hold
450
0.01% 353
2023
Q4
$27.8K Hold
450
﹤0.01% 371
2023
Q3
$26.5K Hold
450
0.01% 360
2023
Q2
$26.9K Hold
450
0.01% 379
2023
Q1
$26.3K Hold
450
0.01% 377
2022
Q4
$27.9K Hold
450
0.01% 321
2022
Q3
$25K Hold
450
0.01% 324
2022
Q2
$29K Hold
450
0.01% 362
2022
Q1
$29K Hold
450
0.01% 381
2021
Q4
$30K Hold
450
0.01% 369
2021
Q3
$27K Hold
450
0.01% 372
2021
Q2
$28K Hold
450
0.01% 360
2021
Q1
$27K Hold
450
0.01% 343
2020
Q4
$27K Hold
450
0.01% 324
2020
Q3
$25K Hold
450
0.01% 296
2020
Q2
$23K Hold
450
0.01% 294
2020
Q1
$20K Buy
+450
New +$22.7K 0.01% 299

Other funds holding IHE

HHM Wealth Advisors's IHE Position: Q2 2026 in Review

HHM Wealth Advisors held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 450 shares worth $44.6K. The position accounts for ﹤0.01% of the portfolio, ranked #403.

HHM Wealth Advisors first reported a position in IHE in Q1 2020 and has held it in 26 quarters since. 58 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • HHM Wealth Advisors held 450 shares of iShares US Pharmaceuticals ETF worth $44.6K as of Q2 2026.
  • HHM Wealth Advisors left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #403 holding.
  • HHM Wealth Advisors first reported a position in iShares US Pharmaceuticals ETF in Q1 2020 and has held it in 26 quarters since.
  • 58 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.